Polypeptide inhibitors of urokinase type plasminogen activator
A conjugate which is capable of specific binding to and inhibition of urokinase-type plasminigen activator (UPA) comprising a polypeptide molecule and a scaffold molecule, wherein said polypeptide molecule is attached to said scaffold molecule by at ...
Winter, Greg +2 more
core
Urokinase plasminogen activator receptor attenuates allergen-induced eosinophil migration and airway hyperresponsiveness. [PDF]
Whitehead GS +10 more
europepmc +1 more source
Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease. [PDF]
Sakr SM +22 more
europepmc +1 more source
The relationship between the urokinase-type plasminogen activator gene Pro141Leu polymorphism and patients with prostate cancer. [PDF]
Gülüm C +3 more
europepmc +1 more source
Plasminogen activator, urokinase receptor (PLAUR; UPAR) [PDF]
openaire +1 more source
Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer. [PDF]
Izuegbuna OO.
europepmc +1 more source
Integrin α5β1 mediates the inhibitory effects of vasoinhibin on angiogenesis and vascular permeability. [PDF]
Zamora M +3 more
europepmc +1 more source
Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]
Al Shaer NSH +5 more
europepmc +1 more source
Targeted Interference with USF2 Binding to the SERPINE1 Proximal Promoter E-Box in Dual Mutant p53<sup>R282Q,H179Y</sup> Human Keratinocytes Inhibits Serum-/TGF-β1-Induced SERPINE1 Expression and Stimulates Epithelial Cell Proliferation. [PDF]
Higgins SP +3 more
europepmc +1 more source

